Urofollitropin Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 75 IU per vial
Reference Brands: Fostimon® , Follitrope® (EU); Bravelle®, Follistim®(US)
Category: Women's Health
Urofollitropin Injection is a purified FSH used in fertility treatments in the EU and US. It supports ovarian stimulation and ovulation induction in ART procedures like IVF. Available as injectable vials (75 IU) under brands such as Fostimon® (EU) and Bravelle® (US), it is trusted by fertility clinics and pharmacies. Urofollitropin is available in Injection and strengths such as 75 IU per vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Urofollitropin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Urofollitropin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Urofollitropin Injection is a purified follicle-stimulating hormone (FSH) derived from postmenopausal women’s urine, widely used in fertility treatments across the EU and US. It plays a crucial role in controlled ovarian stimulation and ovulation induction for assisted reproductive technologies (ART), including IVF. Available in injectable forms—such as 75 IU vials under brand names like Fostimon® (EU) and Bravelle® (US)—urofollitropin supports effective follicular development with a proven safety profile. This hormone therapy is in high demand among fertility clinics, hospitals, and specialty pharmacies, making it a key product in pharmaceutical B2B supply chains in regulated markets.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Norethindrone Acetate
Strength:
0.35 mg, 1 mg, 5 mg, 10 mg
Form: Tablets
Reference Brands: Aygestin (USA), Jolivette (USA), Heather (USA)
View DetailsEtonogestrel
Strength:
68 mg
Form: Subcutaneous implant
Reference Brands: Nexplanon (USA)
View DetailsRelugolix+ Estradiol + Norethindrone
Strength:
40 mg+ 1 mg + 0.5 mg
Form: Tablets
Reference Brands: Myfembree (USA)
View DetailsMifepristone
Strength:
200 mg, 300 mg
Form: Tablets
Reference Brands: Mifeprex (USA), Mifegyne (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers